Evidence map›Paper›PMID 32652095›Full record

ReviewChest2020

Addressing Reduced Laboratory-Based Pulmonary Function Testing During a Pandemic.

Andrew Kouri, Samir Gupta, Azadeh Yadollahi, Clodagh M Ryan, Andrea S Gershon, Teresa To, Susan M Tarlo, Roger S Goldstein, Kenneth R Chapman, Chung-Wai Chow

Registry-linked trialOpen access · bronzeAbstract readReview
PubMed Full text at PMC Publisher
In one paragraph

Review in Chest, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT05047419 (Using Mobile Health Approaches to Improve Asthma Treatment), which is not on this map. Cited by 48 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
48citing papers in PubMed, 2 pooled it
8.5field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT05047419 completednot on this mapstarted 2021, after this paper: background citation

Using Mobile Health Approaches to Improve Asthma Treatment

TypeobservationalSponsorLinnea PolgreenRan2021 to 2023Enrolled83ConditionsAsthma, Pregnancy
3 · Its place in the literature

Who cites it

48 citing papers in PubMed, 2 syntheses or guidelines pooled it, 91 citations in OpenAlex.

  1. The Role of Access and Cost-Effectiveness in Managing Asthma: A Systematic Review.The journal of allergy and clinical immunology. In practice · 2022
    Pooled it
  2. Pooled it
  3. Trial
  4. Feasibility and acceptability of home monitoring with portable spirometry in young adults with asthma.The Journal of asthma : official journal of the Association for the Care of Asthma · 2023
    Trial
  5. Trial
  6. Article
  7. Review
  8. Review
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Review
  17. Article
  18. COVID-19 Pandemic and Healthcare Communication: A Patient-Centric Evaluation of Treatment and Diagnostic Procedures in Poland.Medical science monitor : international medical journal of experimental and clinical research · 2023
    Article
  19. Digital health in chronic obstructive pulmonary disease.Chronic diseases and translational medicine · 2023
    Review
  20. Mobile Health for Asthma.CHEST pulmonary · 2023
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 7 institutions in 3 countries.

Andrew KouriDivision of Respirology, Department of Medicine, St. Michael's Hospital, Unity Health Toronto, Toronto, ON. Electronic address: andrew.kouri@mail.utoronto.ca.
Samir GuptaDivision of Respirology, Department of Medicine, St. Michael's Hospital, Unity Health Toronto, Toronto, ON; Department of Medicine, University of Toronto, Toronto, ON.
Azadeh YadollahiInstitute of Biomaterials and Biomedical Engineering, University of Toronto, Toronto, ON; KITE-Toronto Rehabilitation Institute, University Health Network, Toronto, ON.
Clodagh M RyanDepartment of Medicine, University of Toronto, Toronto, ON; Division of Respirology, Department of Medicine, Toronto General Hospital, University Health Network, Toronto, ON.
Andrea S GershonDepartment of Medicine, University of Toronto, Toronto, ON; Division of Respirology, Department of Medicine, Sunnybrook Health Sciences Center, Toronto, ON.
Teresa ToChild Health Evaluative Sciences, The Hospital for Sick Children, Toronto, ON; Dalla Lana Graduate School of Public Health, University of Toronto, Toronto, ON.
Susan M TarloDepartment of Medicine, University of Toronto, Toronto, ON; Division of Respirology, Department of Medicine, Toronto Western Hospital, University Health Network, Toronto, ON.
Roger S GoldsteinDepartment of Medicine, University of Toronto, Toronto, ON; Division of Respiratory Medicine, West Part Healthcare Centre, Toronto, ON, Canada.
Kenneth R ChapmanDepartment of Medicine, University of Toronto, Toronto, ON; Division of Respirology, Department of Medicine, Toronto Western Hospital, University Health Network, Toronto, ON.
Chung-Wai ChowDepartment of Medicine, University of Toronto, Toronto, ON; Division of Respirology, Department of Medicine, Toronto General Hospital, University Health Network, Toronto, ON.
Toronto Western Hospital · CAUnity Health TorontoUniversity of Toronto · CASickKids Foundation · CASunnybrook Health Science Centre · CAToronto General Hospital · CAToronto Rehabilitation Institute · CA

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

To reduce the spread of the severe acute respiratory syndrome coronavirus 2, many pulmonary function testing (PFT) laboratories have been closed or have significantly reduced their testing capacity. Because these mitigation strategies may be necessary for the next 6 to 18 months to prevent recurrent peaks in disease prevalence, fewer objective measurements of lung function will alter the diagnosis and care of patients with chronic respiratory diseases. PFT, which includes spirometry, lung volume, and diffusion capacity measurement, is essential to the diagnosis and management of patients with asthma, COPD, and other chronic lung conditions. Both traditional and innovative alternatives to conventional testing must now be explored. These may include peak expiratory flow devices, electronic portable spirometers, portable exhaled nitric oxide measurement, airwave oscillometry devices, and novel digital health tools such as smartphone microphone spirometers and mobile health technologies along with integration of machine learning approaches. The adoption of some novel approaches may not merely replace but could improve existing management strategies and alter common diagnostic paradigms. With these options comes important technical, privacy, ethical, financial, and medicolegal barriers that must be addressed. However, the coronavirus disease 19 pandemic also presents a unique opportunity to augment conventional testing by including innovative and emerging approaches to measuring lung function remotely in patients with respiratory disease. The benefits of such an approach have the potential to enhance respiratory care and empower patient self-management well beyond the current global pandemic.

Indexed as

COVID-19AsthmaBreath TestsChronic DiseaseCystic FibrosisDelivery of Health CareHumansHypertension, PulmonaryInventionsLung DiseasesLung Diseases, InterstitialLung Volume MeasurementsMachine LearningOscillometryPeak Expiratory Flow RatePulmonary Diffusing CapacityasthmaCOPDCOVID-19 pandemicpulmonary function testreviewSARS-CoV-2

Identifiers

PMID32652095
PMCPMC7345485
OpenAlexW3041308915

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.